{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:43:45Z","timestamp":1778867025615,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2019YFC0840607"],"award-info":[{"award-number":["2019YFC0840607"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science and Technology Major Project of China","award":["2017ZX09304010"],"award-info":[{"award-number":["2017ZX09304010"]}]},{"DOI":"10.13039\/501100001809","name":"Program of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82000908"],"award-info":[{"award-number":["82000908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04965-7","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T07:02:55Z","timestamp":1682406175000},"page":"3121-3128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refractive status and retinal morphology in children with a history of intravitreal ranibizumab for retinopathy of prematurity"],"prefix":"10.1007","volume":"182","author":[{"given":"Haixia","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstrom","year":"2013","unstructured":"Hellstrom A, Smith LE, Dammann O (2013) Retinopathy of prematurity. Lancet 382:1445\u20131457","journal-title":"Lancet"},{"key":"4965_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","volume":"218","author":"ME Hartnett","year":"2020","unstructured":"Hartnett ME (2020) Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor. Am J Ophthalmol 218:208\u2013213","journal-title":"Am J Ophthalmol"},{"key":"4965_CR3","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1007\/s00431-021-04140-w","volume":"180","author":"C Lei","year":"2021","unstructured":"Lei C, Duan J, Ge G, Zhang M (2021) Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis. Eur J Pediatr 180:3433\u20133442","journal-title":"Eur J Pediatr"},{"key":"4965_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00431-020-03896-x","volume":"180","author":"G Agrawal","year":"2021","unstructured":"Agrawal G, Dutta S, Prasad R, Dogra MR (2021) Fetal oxidative stress, micronutrient deficiency and risk of retinopathy of prematurity: a nested case-control study. Eur J Pediatr 180:1487\u20131496","journal-title":"Eur J Pediatr"},{"key":"4965_CR5","first-page":"135","volume":"8","author":"HA Mintz-Hittner","year":"2016","unstructured":"Mintz-Hittner HA, Geloneck MM (2016) Review of effects of anti-VEGF treatment on refractive error. Eye Brain 8:135\u2013140","journal-title":"Eye Brain"},{"key":"4965_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","volume":"122","author":"CK Hwang","year":"2015","unstructured":"Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR (2015) Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122:1008\u20131015","journal-title":"Ophthalmology"},{"key":"4965_CR7","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.ophtha.2012.02.040","volume":"119","author":"WC Wu","year":"2012","unstructured":"Wu WC, Lin RI, Shih CP, Wang NK, Chen YP, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC, Huang CY, Tsai S (2012) Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 119:1907\u20131916","journal-title":"Ophthalmology"},{"key":"4965_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00417-017-3662-5","volume":"255","author":"A Fiess","year":"2017","unstructured":"Fiess A, Janz J, Schuster AK, Kolb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J (2017) Macular morphology in former preterm and full-term infants aged 4 to 10 years. Graefes Arch Clin Exp Ophthalmol 255:1433\u20131442","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"850\u2013855","key":"4965_CR9","volume":"153","author":"J Wang","year":"2012","unstructured":"Wang J, Spencer R, Leffler JN, Birch EE (2012) Characteristics of peripapillary retinal nerve fiber layer in preterm children. Am J Ophthalmol 153(850\u2013855):e851","journal-title":"Am J Ophthalmol"},{"key":"4965_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/eye.2015.166","volume":"29","author":"KA Park","year":"2015","unstructured":"Park KA, Oh SY (2015) Retinal nerve fiber layer thickness in prematurity is correlated with stage of retinopathy of prematurity. Eye (Lond) 29:1594\u20131602","journal-title":"Eye (Lond)"},{"issue":"1058\u20131064","key":"4965_CR11","volume":"115","author":"GE Quinn","year":"2008","unstructured":"Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, Good WV, Treatment E, for Retinopathy of Prematurity Cooperative G (2008) Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology 115(1058\u20131064):e1051","journal-title":"Ophthalmology"},{"key":"4965_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","volume":"34","author":"P Sen","year":"2020","unstructured":"Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P (2020) Retinopathy of prematurity treatment: Asian perspectives. Eye (Lond) 34:632\u2013642","journal-title":"Eye (Lond)"},{"key":"4965_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF, Li J, Liew M, Maier R, Zhu Q, Marlow N (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 394:1551\u20131559","journal-title":"Lancet"},{"key":"4965_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/IAE.0000000000000380","volume":"35","author":"SN Chen","year":"2015","unstructured":"Chen SN, Lian I, Hwang YC, Chen YH, Chang YC, Lee KH, Chuang CC, Wu WC (2015) Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab. Retina 35:667\u2013674","journal-title":"Retina"},{"key":"4965_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2147\/OPTH.S110717","volume":"10","author":"CJ Lin","year":"2016","unstructured":"Lin CJ, Tsai YY (2016) Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity. Clin Ophthalmol 10:1323\u20131327","journal-title":"Clin Ophthalmol"},{"key":"4965_CR16","doi-asserted-by":"publisher","first-page":"4565216","DOI":"10.1155\/2018\/4565216","volume":"2018","author":"YC Chen","year":"2018","unstructured":"Chen YC, Chen SN, Yang BC, Lee KH, Chuang CC, Cheng CY (2018) Refractive and biometric outcomes in patients with retinopathy of prematurity treated with intravitreal injection of ranibizumab as compared with bevacizumab: a clinical study of correction at three years of age. J Ophthalmol 2018:4565216","journal-title":"J Ophthalmol"},{"key":"4965_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000489023","volume":"240","author":"S Kimyon","year":"2018","unstructured":"Kimyon S, Mete A (2018) Comparison of Bevacizumab and Ranibizumab in the Treatment of Type 1 Retinopathy of Prematurity Affecting Zone 1. Ophthalmologica 240:99\u2013105","journal-title":"Ophthalmologica"},{"key":"4965_CR18","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1167\/iovs.06-1199","volume":"48","author":"M Ecsedy","year":"2007","unstructured":"Ecsedy M, Szamosi A, Karko C, Zubovics L, Varsanyi B, Nemeth J, Recsan Z (2007) A comparison of macular structure imaged by optical coherence tomography in preterm and full-term children. Invest Ophthalmol Vis Sci 48:5207\u20135211","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4965_CR19","doi-asserted-by":"crossref","unstructured":"Early treatment diabetic retinopathy study research group (1991) Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 98:741\u2013756","DOI":"10.1016\/S0161-6420(13)38009-9"},{"key":"4965_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/bjo.81.1.12","volume":"81","author":"F Laws","year":"1997","unstructured":"Laws F, Laws D, Clark D (1997) Cryotherapy and laser treatment for acute retinopathy of prematurity: refractive outcomes, a longitudinal study. Br J Ophthalmol 81:12\u201315","journal-title":"Br J Ophthalmol"},{"key":"4965_CR21","first-page":"365","volume":"101","author":"B Mueller","year":"2017","unstructured":"Mueller B, Salchow DJ, Waffenschmidt E, Joussen AM, Schmalisch G, Czernik C, Buhrer C, Schunk KU, Girschick HJ, Winterhalter S (2017) Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Br J Ophthalmol 101:365\u2013370","journal-title":"Br J Ophthalmol"},{"key":"4965_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","volume":"5","author":"N Marlow","year":"2021","unstructured":"Marlow N, Stahl A, Lepore D, Fielder A, Reynolds JD, Zhu Q, Weisberger A, Stiehl DP, Fleck B, group Ri, (2021) 2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health 5:698\u2013707","journal-title":"Lancet Child Adolesc Health"},{"key":"4965_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/cxo.13019","volume":"103","author":"Q Meng","year":"2020","unstructured":"Meng Q, Cheng Y, Wu X, Zhao D, Zhao M, Liang J (2020) Refractive error outcomes after intravitreal ranibizumab for retinopathy of prematurity. Clin Exp Optom 103:495\u2013500","journal-title":"Clin Exp Optom"},{"key":"4965_CR24","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1167\/iovs.13-11765","volume":"54","author":"J Wang","year":"2013","unstructured":"Wang J, Ren X, Shen L, Yanni SE, Leffler JN, Birch EE (2013) Development of refractive error in individual children with regressed retinopathy of prematurity. Invest Ophthalmol Vis Sci 54:6018\u20136024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4965_CR25","doi-asserted-by":"publisher","first-page":"7683749","DOI":"10.1155\/2019\/7683749","volume":"2019","author":"J Mao","year":"2019","unstructured":"Mao J, Lao J, Liu C, Wu M, Yu X, Shao Y, Zhu L, Chen Y, Shen L (2019) Factors that influence refractive changes in the first year of myopia development in premature infants. J Ophthalmol 2019:7683749","journal-title":"J Ophthalmol"},{"key":"4965_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.21037\/tp.2020.03.01","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang Y, Pi LH, Zhao RL, Zhu XH, Ke N (2020) Refractive status and optical components of premature babies with or without retinopathy of prematurity at 7 years old. Transl Pediatr 9:108\u2013116","journal-title":"Transl Pediatr"},{"key":"4965_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ajo.2014.12.015","volume":"159","author":"V Pueyo","year":"2015","unstructured":"Pueyo V, Gonzalez I, Altemir I, Perez T, Gomez G, Prieto E, Oros D (2015) Microstructural changes in the retina related to prematurity. Am J Ophthalmol 159:797\u2013802","journal-title":"Am J Ophthalmol"},{"key":"4965_CR28","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1167\/iovs.07-0472","volume":"48","author":"N Cheung","year":"2007","unstructured":"Cheung N, Tong L, Tikellis G, Saw SM, Mitchell P, Wang JJ, Wong TY (2007) Relationship of retinal vascular caliber with optic disc diameter in children. Invest Ophthalmol Vis Sci 48:4945\u20134948","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4965_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ajo.2009.04.006","volume":"148","author":"LS Lim","year":"2009","unstructured":"Lim LS, Saw SM, Cheung N, Mitchell P, Wong TY (2009) Relationship of retinal vascular caliber with optic disc and macular structure. Am J Ophthalmol 148:368\u2013375","journal-title":"Am J Ophthalmol"},{"key":"4965_CR30","first-page":"121","volume":"47","author":"TJ Duggan","year":"2021","unstructured":"Duggan TJ, Cai CL, Aranda JV, Beharry KD (2021) Acute and chronic effects of intravitreal bevacizumab on lung biomarkers of angiogenesis in the rat exposed to neonatal intermittent hypoxia. Exp Lung Res 47:121\u2013135","journal-title":"Exp Lung Res"},{"key":"4965_CR31","doi-asserted-by":"crossref","unstructured":"Morin J, Luu TM, Superstein R, Ospina LH, Lefebvre F, Simard MN, Shah V, Shah PS, Kelly EN, Canadian Neonatal N, the Canadian Neonatal Follow-Up Network I (2016) Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 137","DOI":"10.1542\/peds.2015-3218"},{"key":"4965_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.761398","volume":"8","author":"L Liang","year":"2021","unstructured":"Liang L, Yang Y, Bu S, Lu F (2021) Case report: a case of cotton-wool spots after intravitreal injection of Conbercept in an infant with Incontinentia pigmenti. Front Med (Lausanne) 8:761398","journal-title":"Front Med (Lausanne)"},{"key":"4965_CR33","doi-asserted-by":"publisher","first-page":"23723","DOI":"10.1038\/s41598-021-03179-x","volume":"11","author":"G Calzetti","year":"2021","unstructured":"Calzetti G, Mora P, Borrelli E, Sacconi R, Ricciotti G, Carta A, Gandolfi S, Querques G (2021) Short-term changes in retinal and choroidal relative flow volume after anti-VEGF treatment for neovascular age-related macular degeneration. Sci Rep 11:23723","journal-title":"Sci Rep"},{"key":"4965_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/eye.2017.156","volume":"32","author":"YS Lee","year":"2018","unstructured":"Lee YS, Chang SHL, Wu SC, See LC, Chang SH, Yang ML, Wu WC (2018) The inner retinal structures of the eyes of children with a history of retinopathy of prematurity. Eye (Lond) 32:104\u2013112","journal-title":"Eye (Lond)"},{"key":"4965_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.preteyeres.2016.09.004","volume":"56","author":"RM Hansen","year":"2017","unstructured":"Hansen RM, Moskowitz A, Akula JD, Fulton AB (2017) The neural retina in retinopathy of prematurity. Prog Retin Eye Res 56:32\u201357","journal-title":"Prog Retin Eye Res"},{"key":"4965_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0042-6989(86)90143-4","volume":"26","author":"C Yuodelis","year":"1986","unstructured":"Yuodelis C, Hendrickson A (1986) A qualitative and quantitative analysis of the human fovea during development. Vision Res 26:847\u2013855","journal-title":"Vision Res"},{"key":"4965_CR37","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.ophtha.2011.05.028","volume":"118","author":"RS Maldonado","year":"2011","unstructured":"Maldonado RS, O\u2019Connell RV, Sarin N, Freedman SF, Wallace DK, Cotten CM, Winter KP, Stinnett S, Chiu SJ, Izatt JA, Farsiu S, Toth CA (2011) Dynamics of human foveal development after premature birth. Ophthalmology 118:2315\u20132325","journal-title":"Ophthalmology"},{"key":"4965_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/IAE.0000000000002590","volume":"40","author":"L Dong","year":"2020","unstructured":"Dong L, Kang YK, Li Y, Wei WB, Jonas JB (2020) Prevalence and time trends of myopia in children and adolescents in China: A Systemic Review and Meta-Analysis. Retina 40:399\u2013411","journal-title":"Retina"},{"key":"4965_CR39","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/bjophthalmol-2016-309622","volume":"101","author":"Fiess A, Christian L, Janz J, Kolb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J, Prematurity Eye Study G","year":"2017","unstructured":"Fiess A, Christian L, Janz J, Kolb-Keerl R, Knuf M, Kirchhof B, Muether PS, Bauer J, Prematurity Eye Study G (2017) Functional analysis and associated factors of the peripapillary retinal nerve fibre layer in former preterm and full-term infants. Br J Ophthalmol 101:1405\u20131411","journal-title":"Br J Ophthalmol"},{"key":"4965_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1136\/bjophthalmol-2019-314759","volume":"104","author":"Z Fu","year":"2020","unstructured":"Fu Z, Hong H, Su Z, Lou B, Pan CW, Liu H (2020) Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. Br J Ophthalmol 104:1164\u20131170","journal-title":"Br J Ophthalmol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04965-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:06:20Z","timestamp":1689685580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04965-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04965-7","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of the Children\u2019s Hospital of Nanjing Medical University. Informed consent was obtained from a parent or guardian of each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}